Previous Close | 10.16 |
Open | 10.17 |
Bid | 0.00 x 28000 |
Ask | 0.00 x 800 |
Day's Range | 10.17 - 10.17 |
52 Week Range | 9.70 - 10.17 |
Volume | |
Avg. Volume | 100,336 |
Market Cap | 195.127M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 113.00 |
EPS (TTM) | 0.09 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for ARYD
NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp IV (NASDAQ: ARYD) (“ARYA IV”), a publicly traded special purpose acquisition company sponsored by Perceptive Advisors announced today that, due to existing market conditions, it has mutually agreed with Amicus Therapeutics, Inc. (Nasdaq: FOLD) (“Amicus”) to terminate their previously announced Business Combination Agreement (the “Business Combination Agreement”), effective immediately. “While this is not the outcome we ha